Your drug development solution provider

Integration of preclinical and clinical knowledge to predict intravenous PK in human: bilastine case study.

7 junio, 2016

Vozmediano V, Ortega I, Lukas JC, Gonzalo A, Rodriguez M, Lucero ML.

PMID: 23619917

Be the first to know about our initiatives, news and other related information

RESPONSIBLE: DYNAKIN S.L. PURPOSE: Respond to your information request. RIGHTS: You have the right to access, rectify and delete the data, as well as other rights, as explained in the additional information. ADDITIONAL INFORMATION:You can consult the additional and detailed information on Data Protection here.

I accept the terms of use.

Categories

  • No hay categorías
Contact us

We wish to know from you,
we wish to help you.

RESPONSIBLE: DYNAKIN S.L. PURPOSE: Respond to your information request. RIGHTS: You have the right to access, rectify and delete the data, as well as other rights, as explained in the additional information. ADDITIONAL INFORMATION:You can consult the additional and detailed information on Data Protection here.

I accept the terms of use.

↑